NYSE Content Update: AdvanCell Raises $315 Million to Fight Prostate Cancer
NYSE issues a pre-market daily advisory direct from the trading floor.
NEW YORK, July 17, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.
Ashley Mastronardi delivers the pre-market update on July 17th
- Equities are lower as investors parse through fresh earnings and monitor new activity in the Middle East.
- NYSE Live will provide exclusive access to Standard Nuclear's executive remarks.
- CEO Kurt Terrani will also join the program to explain why now was the perfect time to take the energy company public.
- Shares of STDN began trading on Thursday.
- AdvanCell CEO Philina Lee joins NYSE Live following the firm's $315 million funding round.
- Startup is developing targeted alpha therapies for prostate cancer.
- Company says it will be expanding its manufacturing infrastructure in the U.S.
- Voyager Technologies discloses next steps after receiving a $298 million contract from NASA.
- Firm will conduct pair of lunar landing missions following its acquisition of Astrobotic.
- Chairman + CEO Dylan Taylor will join NYSE Live to discuss how the data will aid NASA's Artemis program.
Opening Bell
Standard Nuclear (NYSE:STDN) celebrates its recent Initial Public Offering
Closing Bell
UWM Holdings (NYSE:UWMC) celebrates of National Mortgage Brokers Day
For market insights, IPO activity, and today's opening bell, download the NYSE TV App: TV.NYSE.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-content-update-advancell-raises-315-million-to-fight-prostate-cancer-302828547.html
SOURCE New York Stock Exchange
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/July2026/17/c3546.html